Vol. 6 (01) pp. 303-308 DOI: 10.21474/IJAR01/6219

ETIOLOGICAL PATTERNS AND FUNCTIONAL CLASS OF PULMONARY HYPERTENSION IN LUNG DISEASES AT A TERTIARY CARE CENTRE IN INDIA- A PROSPECTIVE STUDY.

  • Assistant Professor, Dept. Of Pulmonary Medicine, Dr. D.Y. Patil Medical College, Navi Mumbai.
  • Professor and HOD, Dept. Of Pulmonary medicine, Government Medical College, Trivandrum.
  • Consultant Pulmonologist and DNB Coordinator, Chest hospital, Calicut.
  • Additional Professor, Dept. Of Pulmonary Medicine, Government Medical College, Trivandrum.
  • Associate Professor, Dept. Of Pulmonary Medicine, Government Medical College, Trivandrum.
  • Senior Resident, Dept. Of Pulmonary Medicine, Government Medical College, Trivandrum.
14 Downloads 140 Views
Crossref

Abstract

Introduction: Pulmonary Hypertension (PH) results from multiple etiological factors, whose natural history varies considerably depending on cause and pathophysiology. The data on the etiological pattern of different lung diseases causing pulmonary hypertension is important because a high index of clinical suspicion can be kept on such patients to detect PH. Aims: To prospectively evaluate the etiological pattern of pulmonary hypertension among patients with respiratory diseases coming to our centre. We also aimed to evaluate whether etiology is a determinant of functional class in pulmonary hypertension. Materials and Methods: A prospective observational study of 53 subjects was done. All patients were interviewed about the symptoms and complete physical examination was performed. A baseline echocardiogram was done at the Dept. of Cardiology. All etiologies causing pulmonary hypertension were defined as per predetermined criteria and recorded. Clinical severity assessment was done using WHO- Functional Class, Six minute walk test and echocardiography parameters at the time of presentation. Comparison of the severity parameters were done among the etiologies.The statistical analysis was done using statistical software SPSS Version 16. Results: In this study, the most common etiology of pulmonary hypertension in lung diseases was Chronic Obstructive Pulmonary Disease(51%) followed by Interstitial lung diseases(22%) and Bronchiectasis (17%). Majority of our patients presented with WHO- Functional class- 3. As part of the severity assessment, COPD patients were found to have a significantly low RVSP (Right Ventricular Systolic Pressure) values when compared to other etiologies. There was no significant difference in six minute walk distance and functional performance among the various etiologies. Conclusions: In this study, the most common etiology of pulmonary hypertension in lung diseases was Chronic Obstructive Pulmonary Disease. Most of the patients with Pulmonary Hypertension presented with worse functional performance. COPD patients had a milder pulmonary hypertension when compared to other etiologies.

Keywords

Article Analytics

References

  1. Peacock AJ, Murphy NF, McMurray JJV, Caballero L, Stewart S (2007). An epidemiological study of pulmonary arterial hypertension. Eur. Respir. J Jul;30(1):104?9.
  2. Eduardo M. Moreira, Henning Gall , Maarten J. G. Leening, Lies Lahousse (2015). Prevalence of Pulmonary Hypertension in the General Population: The Rotterdam Study. PLOS ONE| DOI:10.1371/journal.pone.0130072
  3. Butrous G, Ghofrani HA, Grimminger F (2008). Pulmonary vascular disease in the developing world. Circulation.Oct 21; 118(17):1758?66.
  4. Gali? N, Hoeper MM, Humbert M, Torbicki A, Vachiery J-L, Barbera JA (2009). Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur. Heart J.Oct; 30(20):2493?537.
  5. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP (2009). Updated clinical classification of pulmonary hypertension. J. Am. Coll. Cardiol Jun 30;54(1 Suppl):S43?54.
  6. Schannwell CM, Steiner S, Strauer B-E. Diagnostics in pulmonary hypertension(2007). J. Physiol. Pharmacol.Nov;58 Suppl 5(Pt 2):591?602.
  7. Global strategy for the diagnosis, management, and prevention of Chronic obstructive pulmonary disease updated 2017.
  8. Bradley B, Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK (2008). Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. Sep;63 Suppl 5:v1?58.
  9. Pasteur MC, Bilton D, Hill AT. British Thoracic Society guideline for non-CF bronchiectasis(2010). Thorax. Jul;65 Suppl 1:i1?58.
  10. Hyduk A, Croft JB, Ayala C, Zheng K, Zheng Z-J, Mensah GA(2005). Pulmonary hypertension surveillance--United States, 1980-2002. MMWR Surveill Summ.Nov 11; 54(5):1?28.
  11. Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF(2006). Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis.Chest. 2006 Mar; 129(3):746?52.
  12. Mathai SC, Hummers LK, Champion HC, Wigley FM, Zaiman A, Hassoun PM (2009). Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease. Arthritis Rheum, Feb;60(2):569?77.
  13. Minai OA, Chaouat A, Adnot S (2010). Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective. Chest. Jun; 137(6 Suppl):39S?51S.

How to Cite This Article

Jayamol Ravindran, Anithakumari Kumaran, Cheriyavalappil Puthiyapura Rauf, Jayaprakash Balakrishnan, Nair Sanjeev and Sindhu Mechiramarath Divakaran. (2018); ETIOLOGICAL PATTERNS AND FUNCTIONAL CLASS OF PULMONARY HYPERTENSION IN LUNG DISEASES AT A TERTIARY CARE CENTRE IN INDIA- A PROSPECTIVE STUDY., Int. J. of Adv. Res., 6 (01), 303-308, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/6219

Corresponding Author

Dr Jayamol Revendran
Department of Pulmonary Medicine, D Y Patil Medical College, Nerul, Mumbai